Brainsway Ltd. (BWAY)
BrainsWay makes Deep TMS magnetic brain stimulation systems used to treat mental health disorders. It last closed at $8.48 on Nov 20, down 2.86% on the day.
Key Stats
Last 12 monthsNot reported for this period.
From BWAY's SEC filings, latest 20-F for the period ending Jun 30, 2025 (filed Apr 20). Last 12 months adds up the four latest quarters. Per share figures are left out because the US listing can represent a different number of shares.
Earnings
Full earnings history →Analyst Ratings & Price Targets
Analyst Ratings →- Every upgrade, downgrade and initiation as it happens
- Every price target change, raised or cut
- Consensus rating with the average, high and low targets
- Each firm's full rating history on BWAY
Technical AnalysisPrices may be delayed
The stock is 25% below its 20 day and 38% below its 50 day average. It is 63% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 28), oversold. The nearest support is the Pivot S1 at $8.30, and the nearest resistance the Pivot at $8.63.
| RSI (14) | 27.90 | Oversold below 30 | Oversold |
| MACD | -0.85 | Below its signal line | Bearish |
| Stochastic | 2.3 | Near the bottom of its range | Oversold |
| ADX (14) | 25.0 | Trending down | |
| Williams %R | -99.2 | Oversold below −80, overbought above −20 | Oversold |
| CCI (20) | -154.8 | Oversold below −100, overbought above 100 | Oversold |
| Rate of change | −23.9% | Change over 10 sessions | Bearish |
| ATR (14) | $0.66 | Typical daily range, 7.8% of price |
| RSI (14) | 23.73 | Oversold below 30 | Oversold |
| MACD | -1.03 | Below its signal line | Bearish |
| Stochastic | 5.0 | Near the bottom of its range | Oversold |
| ADX (14) | 22.0 | Weak trend | |
| Williams %R | -99.6 | Oversold below −80, overbought above −20 | Oversold |
| CCI (20) | -173.9 | Oversold below −100, overbought above 100 | Oversold |
| Rate of change | −39.1% | Change over 10 sessions | Bearish |
| ATR (14) | $1.39 | Typical daily range, 16.4% of price |
What happened before
See how BWAY did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How BWAY has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2019.
Whale Options FlowPrices may be delayed
90DNo whale options trades in BWAY in the last 90 days.
BWAY Institutional Ownership
Full report →- ●29 buying vs 27 selling
- ●Shares held by funds -0.7%
- ▲Funds holding +9
- ▼Superinvestors: 1 added, 2 cut
- ●Put/call not meaningful
| Q3 2026 | This quarter | Last quarter | Change |
|---|---|---|---|
| Funds holding | 65 | 56 | +16.1% |
| In funds' top 10 | 1 | 1 | 0.0% |
| Held by funds | – | – | – |
| New / increased | 18 / 11 | 8 / 15 | +26.1% |
| Reduced / sold out | 18 / 9 | 19 / 8 | 0.0% |
| Put/call ratio | – | – | – |
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper tradingStreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether BWAY is in one of them and how their past BWAY trades turned out.
BWAY News Tone and PricePrices may be delayed
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered BWAY in an article yet. Here's the latest on the wider market.
- Leading the next phase of interventional psychiatry Technology. Evidence. Scale. Growth. N o v e m b e r 2026 I N V E S T O R D E C K | Nasdaq / TASE: BWAY
- BrainsWay Reports Third Quarter 2026 Financial Results and Operational
- BrainsWay Announces Strategic Collaboration with Mindful Health Solutions
- BrainsWay Expands U.S. Insurance Coverage for Deep TMS™ Treatment of OCD to Over 118 Million Lives
- Notice of Annual General Meeting of Shareholders
About Brainsway
BrainsWay is a medical technology company based in Jerusalem, Israel. It makes Deep TMS systems, which use magnetic pulses to stimulate brain regions in a noninvasive way to treat mental health conditions. The treatments are cleared in the United States for depression, including anxious depression, and obsessive-compulsive disorder, and the company markets them for smoking addiction. It sells its systems to psychiatrists' offices and other treatment facilities that care for these patients.
- Headquarters
- Jerusalem, Israel
- Founded
- 2003
- Website
- brainsway.com ↗


